本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Phathom Pharmaceuticals

8.57
+0.67008.48%
盘后8.53-0.0400-0.47%19:26 EDT
成交量:147.61万
成交额:1,243.47万
市值:5.97亿
市盈率:-1.65
高:8.72
开:8.05
低:7.85
收:7.90
数据加载中...
2024/06/15

SEC问询函

Form CORRESP - Correspondence
2024/06/14

[修订]年度报告

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
2024/06/14

[修订]季度报告

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
2024/06/06

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/05/24

重要事件披露

Form 8-K - Current report
2024/05/09

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/09

重要事件披露

Form 8-K - Current report
2024/04/10

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/04/01

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/03/07

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/07

重要事件披露

Form 8-K - Current report
2024/02/13

重要事件披露

Form 8-K - Current report
2024/02/12

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/09

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/26

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/25

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/12/15

重要事件披露

Form 8-K - Current report
2023/12/14

重要事件披露

Form 8-K - Current report
2023/12/06

重要事件披露

Form 8-K - Current report
2023/11/28

重要事件披露

Form 8-K - Current report